缩写名/全名 |
J ENZYM INHIB MED CH
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY |
||||||||||||||||||||
ISSN号 | 1475-6366 | ||||||||||||||||||||
研究方向 | 医学-生化与分子生物学 | ||||||||||||||||||||
影响因子 | 2015:3.428, 2016:4.293, 2017:3.638, 2018:4.027, 2019:4.673, | ||||||||||||||||||||
出版国家 | ENGLAND | ||||||||||||||||||||
出版周期 | Bimonthly | ||||||||||||||||||||
年文章数 | 165 | ||||||||||||||||||||
出版年份 | 2002 | ||||||||||||||||||||
是否OA | Yes | ||||||||||||||||||||
审稿周期(仅供参考) | 偏慢,4-8周 |
||||||||||||||||||||
录用比例 | 容易 | ||||||||||||||||||||
投稿链接 | https://mc.manuscriptcentral.com/genz | ||||||||||||||||||||
投稿官网 | http://www.tandfonline.com/loi/ienz20 | ||||||||||||||||||||
h-index | 61 | ||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1475-6366%5BISSN%5D | ||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Discovery of cyanopyridine scaffold as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors through virtual screening and preliminary hit optimisation. Author: Xu X1,2, Ren J1,2, Ma Y1,2, Liu H1, Rong Q1, Feng Y1, Wang Y1, Cheng Y1, Ge R3, Li Z1,2, Bian J1,2. Journal: J Enzyme Inhib Med Chem. 2019 Dec;34(1):250-263. doi: 10.1080/14756366.2018.1480614. PubMed DOI |
2. | Hydroxyl-substituted double Schiff-base condensed 4-piperidone/cyclohexanones as potential anticancer agents with biological evaluation. Author: Zhang L1, Chen Q2, Hou G1, Zhao W1, Hou Y1. Journal: J Enzyme Inhib Med Chem. 2019 Dec;34(1):264-271. doi: 10.1080/14756366.2018.1501042. PubMed DOI |
3. | Synthesis and biological evaluation of 3-arylcoumarins as potential anti-Alzheimer's disease agents. Author: Yang J1,2,3,4, Zhang P1,2,3,4, Hu Y1,2,3,4, Liu T1,2,3,4, Sun J1,2,3,4, Wang X1,2,3,4. Journal: J Enzyme Inhib Med Chem. 2019 Dec;34(1):651-656. doi: 10.1080/14756366.2019.1574297. PubMed DOI |
4. | Aberrant regulation favours matriptase proteolysis in neoplastic B-cells that co-express HAI-2. Author: Chiu YL1,2, Wu YY3, Barndt RB1, Yeo YH1, Lin YW1,2, Sytwo HP4, Liu HC1,5, Xu Y1, Jia B1,6, Wang JK2, Johnson MD1, Lin CY1. Journal: J Enzyme Inhib Med Chem. 2019 Dec;34(1):692-702. doi: 10.1080/14756366.2019.1577831. PubMed DOI |
5. | Inhibition potential of phenolic constituents from the aerial parts of Tetrastigma hemsleyanum against soluble epoxide hydrolase and nitric oxide synthase. Author: Wang CY1, Lee S1, Jang HJ2, Su XD1, Wang HS3, Kim YH1, Yang SY1. Journal: J Enzyme Inhib Med Chem. 2019 Dec;34(1):753-760. doi: 10.1080/14756366.2019.1584621. PubMed DOI |
6. | Design, synthesis and biological evaluation of novel 4-anlinoquinazoline derivatives as EGFR inhibitors with the potential to inhibit the gefitinib-resistant nonsmall cell lung cancers. Author: Wang C1, Xu S1, Peng L1, Zhang B1, Zhang H1, Hu Y1, Zheng P1, Zhu W1. Journal: J Enzyme Inhib Med Chem. 2019 Dec;34(1):203-217. doi: 10.1080/14756366.2018.1518957. PubMed DOI |
7. | Synthesis and biological evaluation of ursolic acid derivatives bearing triazole moieties as potential anti-Toxoplasma gondii agents. Author: Luan T1, Jin C1, Jin CM1, Gong GH2,3, Quan ZS1. Journal: J Enzyme Inhib Med Chem. 2019 Dec;34(1):761-772. doi: 10.1080/14756366.2019.1584622. PubMed DOI |
8. | CRISPR/Cas9-based liver-derived reporter cells for screening of mPGES-1 inhibitors. Author: Chen Z1, Cai X1, Li M1, Yan L1, Wu L1, Wang X1, Tang N1,2. Journal: J Enzyme Inhib Med Chem. 2019 Dec;34(1):799-807. doi: 10.1080/14756366.2019.1587416. PubMed DOI |
9. | Discovery of novel coumarin derivatives as potent and orally bioavailable BRD4 inhibitors based on scaffold hopping. Author: Zhang Z1, Gu L1, Wang B1, Huang W1, Zhang Y2, Ma Z1, Zeng S1, Shen Z1. Journal: J Enzyme Inhib Med Chem. 2019 Dec;34(1):808-817. doi: 10.1080/14756366.2019.1587417. PubMed DOI |
10. | The antitumor activity of CYB-L10, a human topoisomerase IB catalytic inhibitor. Author: Yu Q1, Chen Y1, Yang H1, Zhang HL1, Agama K2, Pommier Y2, An LK1. Journal: J Enzyme Inhib Med Chem. 2019 Dec;34(1):818-822. doi: 10.1080/14756366.2018.1516651. PubMed DOI |
|
|